Patients can access specialist gastroenterology, internal medicine, dermatology, pain therapy, all provided by an exceptional medical team, coordinated by Prof. Dr. Radu Badea.

“Cluj is one of the most important points of interest in our development plan. First we opened a laboratory and an occupational medicine center in Cluj, and then expanded with a large clinic – MedLife Hyperclinic. Two years ago, we added the hospital segment with the acquisition of Humanitas Hospital. Because we want to provide our patients with a wider range of medical services and personalized subscriptions to tens of thousands of corporate clients, we have decided to team up with the specialists of Badea Medica Center of Excellence in order to provide integrated services to the highest standards. We will continue our acquisition program both in Romania and in the neighboring countries, following the plan announced to our investors and shareholders,” said Mihai Marcu, President and CEO of MedLife.

Badea Medica, with a turnover of RON1.6 million and a profit of RON101.714 in 2017, according to the latest Finance Ministry data, offers a comprehensive range of medical services, mainly focused on the segment of abdominal pathology, but also covering other numerous types of affections.

“We have always focused on the highest quality services and have always honored our patients’ trust in our services and in the exceptional team of specialists. Becoming part of the largest private medical services group in Romania and sharing the same values honors us and encourages us to be even better. We will have the opportunity to develop the business and make an important step in the company’s evolution. By doing so, we will advance the complexity of the medical act and offer patients the best conditions and solutions to their requests,” said Prof. Dr. Radu Ion Badea, founder of Badea Medica Center.

This is MedLife group’s 23rd acquisition to date; the latest acquisition, of Hungary’s Rózsakert Medical Center, was announced in January 2019. 

MedLife ended the first quarter of 2019 with pro-forma consolidated sales of RON224.9 million, up 27.6% compared to the year-earlier period. For the next period, the company announced the continuation of the acquisition program in Romania and in the region. If it succeeds in implementing all the projects announced to shareholders, MedLife is likely to exceed the threshold of EUR200 million sales in 2019.